CoChat
Sign Up
Cited by 252

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Role of MicroRNAs in Colorectal Cancer

Schetter, Aaron J., Okayama, Hirokazu, Harris, Curtis C.·2012·The Cancer Journal
DOI 10.1097/ppo.0b013e318258b78fPMC PMC3397427
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ppo.0b013e318258b78f

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 101

  1. Jemal, 2010, . Cancer statistics, 2010., CA Cancer J Clin, 60, 277, 10.3322/caac.20073 · DOI · Paper page
  2. Chua, 2008, Progress and challenges in the adjuvant treatment of stage II and III colon cancers., Expert Rev Anticancer Ther, 8, 595, 10.1586/14737140.8.4.595 · DOI
  3. Wolpin, 2008, Systemic treatment of colorectal cancer., Gastroenterology, 134, 1296, 10.1053/j.gastro.2008.02.098 · DOI
  4. Rousseau, 2010, . Stage II and stage III colon cancer: treatment advances and future directions., Cancer J, 16, 202, 10.1097/PPO.0b013e3181ddc5bf · DOI
  5. Calin, 2002, . Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia., Proc Natl Acad Sci U S A, 99, 15524, 10.1073/pnas.242606799 · DOI · Paper page
  6. Luo, 2011, Tao S, et al.., MicroRNA signatures: novel biomarker for colorectal cancer Cancer Epidemiol Biomarkers Prev, 20, 1272
  7. Cummins, 2006, . The colorectal microRNAome., Proc Natl Acad Sci U S A, 103, 3687, 10.1073/pnas.0511155103 · DOI · Paper page
  8. Schetter, 2008, . MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma., JAMA, 299, 425, 10.1001/jama.299.4.425 · DOI
  9. Volinia, 2006, . A microRNA expression signature of human solid tumors defines cancer gene targets., Proc Natl Acad Sci U S A, 103, 2257, 10.1073/pnas.0510565103 · DOI · Paper page
  10. Lu, 2005, . MicroRNA expression profiles classify human cancers., Nature, 435, 834, 10.1038/nature03702 · DOI
  11. Lamy, 2006, Dyrskjot L, et al.., Are microRNAs located in genomic regions associated with cancer Br J Cancer, 95, 1415
  12. Calin, 2004, . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers., Proc Natl Acad Sci U S A, 101, 2999, 10.1073/pnas.0307323101 · DOI
  13. Michael, 2003, SM OC, van Holst Pellekaan NG, et al.. Reduced accumulation of specific microRNAs in colorectal neoplasia., Mol Cancer Res, 1, 882
  14. Akao, 2010, . Role of anti-oncomirs miR-143 and -145 in human colorectal tumors., Cancer Gene Ther, 17, 398, 10.1038/cgt.2009.88 · DOI
  15. Suzuki, 2011, . Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer., Cancer Res, 71, 5646, 10.1158/0008-5472.CAN-11-1076 · DOI
  16. Brueckner, 2007, . The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function., Cancer Res, 67, 1419, 10.1158/0008-5472.CAN-06-4074 · DOI
  17. Toyota, 2008, . Epigenetic silencing of microRNA-34bc and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer., Cancer Res, 68, 4123, 10.1158/0008-5472.CAN-08-0325 · DOI
  18. Grady, 2008, . Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer., Oncogene, 27, 3880, 10.1038/onc.2008.10 · DOI · Paper page
  19. Agirre, 2009, . Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia., Cancer Res, 69, 4443, 10.1158/0008-5472.CAN-08-4025 · DOI
  20. Ng, 2009, . MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer., Br J Cancer, 101, 699, 10.1038/sj.bjc.6605195 · DOI
  21. Wang, 2011, . MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1., Carcinogenesis, 32, 1033, 10.1093/carcin/bgr081 · DOI
  22. Lanza, 2007, . mRNAmicroRNA gene expression profile in microsatellite unstable colorectal cancer., Mol Cancer, 6, 54, 10.1186/1476-4598-6-54 · DOI
  23. Lanza, 2009, . Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states., BMC Cancer, 9, 401, 10.1186/1471-2407-9-401 · DOI
  24. Schepeler, 2008, . Diagnostic and prognostic microRNAs in stage II colon cancer., Cancer Res, 68, 6416, 10.1158/0008-5472.CAN-07-6110 · DOI
  25. Valeri, 2010, . Modulation of mismatch repair and genomic stability by miR-155., Proc Natl Acad Sci U S A, 107, 6982, 10.1073/pnas.1002472107 · DOI
  26. Valeri, 2010, . MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)., Proc Natl Acad Sci U S A, 107, 21098, 10.1073/pnas.1015541107 · DOI
  27. Mosakhani, 2012, . MicroRNA profiling differentiates colorectal cancer according to KRAS status., Genes Chromosomes Cancer, 51, 1, 10.1002/gcc.20925 · DOI
  28. Oberg, 2011, . miRNA expression in colon polyps provides evidence for a multihit model of colon cancer., PLoS One, 6, e20465, 10.1371/journal.pone.0020465 · DOI
  29. Slaby, 2007, . Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer., Oncology, 72, 397, 10.1159/000113489 · DOI
  30. Yamamichi, 2009, . Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development., Clin Cancer Res, 15, 4009, 10.1158/1078-0432.CCR-08-3257 · DOI
  31. Nagel, 2008, . Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer., Cancer Res, 68, 5795, 10.1158/0008-5472.CAN-08-0951 · DOI
  32. Diosdado, 2009, . MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression., Br J Cancer, 101, 707, 10.1038/sj.bjc.6605037 · DOI
  33. Balaguer, 2010, . Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis., Cancer Res, 70, 6609, 10.1158/0008-5472.CAN-10-0622 · DOI
  34. Bartkova, 2006, . Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints., Nature, 444, 633, 10.1038/nature05268 · DOI · Paper page
  35. Akao, 2007, MicroRNA-143 and -145 in colon cancer., DNA Cell Biol, 26, 311, 10.1089/dna.2006.0550 · DOI
  36. Chen, 2009, . Role of miR-143 targeting KRAS in colorectal tumorigenesis., Oncogene, 28, 1385, 10.1038/onc.2008.474 · DOI
  37. Shi, 2007, . Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells., J Biol Chem, 282, 32582, 10.1074/jbc.M702806200 · DOI
  38. Sachdeva, 2009, . p53 represses c-Myc through induction of the tumor suppressor miR-145., Proc Natl Acad Sci U S A, 106, 3207, 10.1073/pnas.0808042106 · DOI
  39. Gregersen, 2010, . MicroRNA-145 targets YES and STAT1 in colon cancer cells., PLoS One, 5, e8836, 10.1371/journal.pone.0008836 · DOI
  40. Zhang, 2011, . Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene., Cancer, 117, 86, 10.1002/cncr.25522 · DOI
  41. Xu, 2009, . MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells., Cell, 137, 647, 10.1016/j.cell.2009.02.038 · DOI
  42. Lu, 2008, . MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene., Oncogene, 27, 4373, 10.1038/onc.2008.72 · DOI · Paper page
  43. Meng, 2007, . MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer., Gastroenterology, 133, 647, 10.1053/j.gastro.2007.05.022 · DOI · Paper page
  44. Wang, 2009, . microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells., Cancer Res, 69, 8157, 10.1158/0008-5472.CAN-09-1996 · DOI · Paper page
  45. Zhu, 2008, . MicroRNA-21 targets tumor suppressor genes in invasion and metastasis., Cell Res, 18, 350, 10.1038/cr.2008.24 · DOI · Paper page
  46. Fujita, 2008, . miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism., J Mol Biol, 378, 492, 10.1016/j.jmb.2008.03.015 · DOI
  47. Zhu, 2007, . MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)., J Biol Chem, 282, 14328, 10.1074/jbc.M611393200 · DOI · Paper page
  48. Cottonham, 2010, miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells., J Biol Chem, 285, 35293, 10.1074/jbc.M110.160069 · DOI
  49. Liu, 2011, . miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells., FEBS Lett, 585, 2998, 10.1016/j.febslet.2011.08.014 · DOI
  50. Baraniskin, 2012, . MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL., Carcinogenesis, 33, 732, 10.1093/carcin/bgs020 · DOI · Paper page
  51. Braun, 2008, . p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest., Cancer Res, 68, 10094, 10.1158/0008-5472.CAN-08-1569 · DOI
  52. Wu, 2012, . MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1., Carcinogenesis, 33, 519, 10.1093/carcin/bgr304 · DOI
  53. Strillacci, 2009, . MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells., Exp Cell Res, 315, 1439, 10.1016/j.yexcr.2008.12.010 · DOI
  54. Bandres, 2009, . microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells., Clin Cancer Res, 15, 2281, 10.1158/1078-0432.CCR-08-1818 · DOI
  55. Liu, 2011, . MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4., Carcinogenesis, 32, 1798, 10.1093/carcin/bgr213 · DOI
  56. Tsang, 2010, . Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer., Carcinogenesis, 31, 350, 10.1093/carcin/bgp181 · DOI
  57. Nie, 2012, . microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting cyclin D1 and Bcl-2., Carcinogenesis, 33, 220, 10.1093/carcin/bgr245 · DOI
  58. Ding, 2011, . APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis., J Clin Invest, 121, 4526, 10.1172/JCI45008 · DOI
  59. Huang, 2011, . MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma., Cancer Res, 71, 2582, 10.1158/0008-5472.CAN-10-3032 · DOI
  60. Ryan, 2010, Genetic variation in microRNA networks: the implications for cancer research., Nat Rev Cancer, 10, 389, 10.1038/nrc2867 · DOI
  61. Zhan, 2011, . A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population., Arch Med Res, 42, 144, 10.1016/j.arcmed.2011.04.001 · DOI
  62. Landi, 2008, . Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer., Carcinogenesis, 29, 579, 10.1093/carcin/bgm304 · DOI
  63. Zanetti, 2012, . 3-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans., Cancer Res, 72, 1467, 10.1158/0008-5472.CAN-11-3073 · DOI
  64. Lee, 2010, . Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer., J Cancer Res Clin Oncol, 136, 1073, 10.1007/s00432-009-0754-6 · DOI
  65. Graziano, 2010, . Genetic modulation of the Let-7 microRNA binding to KRAS 3-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan., Pharmacogenomics J, 10, 458, 10.1038/tpj.2010.9 · DOI
  66. Zhang, 2011, . A let-7 microRNA-binding site polymorphism in 3-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy., Ann Oncol, 22, 104, 10.1093/annonc/mdq315 · DOI
  67. Smits, 2011, . A let-7 microRNA SNP in the KRAS 3UTR is prognostic in early-stage colorectal cancer., Clin Cancer Res, 17, 7723, 10.1158/1078-0432.CCR-11-0990 · DOI
  68. Ng, 2009, . Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening., Gut, 58, 1375, 10.1136/gut.2008.167817 · DOI · Paper page
  69. Huang, 2010, . Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer., Int J Cancer, 127, 118, 10.1002/ijc.25007 · DOI
  70. Cheng, 2011, . Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis., PLoS One, 6, e17745, 10.1371/journal.pone.0017745 · DOI
  71. Link, 2010, . Fecal microRNAs as novel biomarkers for colon cancer screening., Cancer Epidemiol Biomarkers Prev, 19, 1766, 10.1158/1055-9965.EPI-10-0027 · DOI
  72. Koga, 2010, . MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening., Cancer Prev Res (Phila), 3, 1435, 10.1158/1940-6207.CAPR-10-0036 · DOI
  73. Kalimutho, 2011, . Epigenetically silenced miR-34bc as a novel faecal-based screening marker for colorectal cancer., Br J Cancer, 104, 1770, 10.1038/bjc.2011.82 · DOI
  74. Shibuya, 2010, . Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer., Oncology, 79, 313, 10.1159/000323283 · DOI
  75. Kulda, 2010, . Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases., Cancer Genet Cytogenet, 200, 154, 10.1016/j.cancergencyto.2010.04.015 · DOI
  76. Nielsen, 2011, . High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients., Clin Exp Metastasis, 28, 27, 10.1007/s10585-010-9355-7 · DOI
  77. Yanaihara, 2006, . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis., Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 · DOI · Paper page
  78. Yan, 2008, . MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis., Rna, 14, 2348, 10.1261/rna.1034808 · DOI
  79. Dillhoff, 2008, . MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival., J Gastrointest Surg, 12, 2171, 10.1007/s11605-008-0584-x · DOI
  80. Li, 2009, . MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor., Clin Cancer Res, 15, 3998, 10.1158/1078-0432.CCR-08-3053 · DOI
  81. Jiang, 2011, . Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1oxaliplatin or doxifluridineoxaliplatin., PLoS One, 6, e23271, 10.1371/journal.pone.0023271 · DOI
  82. Avissar, 2009, . MicroRNA expression in head and neck cancer associates with alcohol consumption and survival., Carcinogenesis, 30, 2059, 10.1093/carcin/bgp277 · DOI
  83. Rossi, 2010, . microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival., Blood, 116, 945, 10.1182/blood-2010-01-263889 · DOI
  84. Zhi, 2010, . The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma., Eur J Cancer, 46, 1640, 10.1016/j.ejca.2010.02.003 · DOI
  85. Diaz, 2008, . Deregulated expression of miR-106a predicts survival in human colon cancer patients., Genes Chromosomes Cancer, 47, 794, 10.1002/gcc.20580 · DOI
  86. Nishida, 2011, . MicroRNA miR-125b is a prognostic marker in human colorectal cancer., Int J Oncol, 38, 1437
  87. Drebber, 2011, . Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy., Int J Oncol, 39, 409
  88. Akcakaya, 2011, . miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer., Int J Oncol, 39, 311
  89. Karaayvaz, 2011, . Prognostic significance of miR-215 in colon cancer., Clin Colorectal Cancer, 10, 340, 10.1016/j.clcc.2011.06.002 · DOI · Paper page
  90. Faber, 2011, . Overexpression of Dicer predicts poor survival in colorectal cancer., Eur J Cancer, 47, 1414, 10.1016/j.ejca.2011.01.006 · DOI
  91. Schetter, 2009, . Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma., Clin Cancer Res, 15, 5878, 10.1158/1078-0432.CCR-09-0627 · DOI
  92. Rossi, 2007, Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro., Pharmacol Res, 56, 248, 10.1016/j.phrs.2007.07.001 · DOI
  93. Song, 2009, . Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells., Oncogene, 28, 4065, 10.1038/onc.2009.274 · DOI
  94. Song, 2010, . Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells., Mol Cancer, 9, 96, 10.1186/1476-4598-9-96 · DOI
  95. Mencia, 2011, . Underexpression of miR-224 in methotrexate resistant human colon cancer cells., Biochem Pharmacol, 82, 1572, 10.1016/j.bcp.2011.08.009 · DOI
  96. Chai, 2011, . miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines., Acta Biochim Biophys Sin (Shanghai), 43, 217, 10.1093/abbs/gmq125 · DOI
  97. Elmen, 2008, . LNA-mediated microRNA silencing in non-human primates., Nature, 452, 896, 10.1038/nature06783 · DOI · Paper page
  98. Lanford, 2010, . Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection., Science, 327, 198, 10.1126/science.1178178 · DOI · Paper page
  99. Gumireddy, 2008, . Small-molecule inhibitors of microRNA miR-21 function., Angew Chem Int Ed Engl, 47, 7482, 10.1002/anie.200801555 · DOI
  100. Young, 2010, . Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma., J Am Chem Soc, 132, 7976, 10.1021/ja910275u · DOI
  101. Ibrahim, 2011, . MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma., Cancer Res, 71, 5214, 10.1158/0008-5472.CAN-10-4645 · DOI

Cited by

Sorted by citations

See all 252

Metadata

Authors
Schetter, A. J., Okayama, H., & Harris, C. C.
Venue
The Cancer Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2012-05
Volume
18
Issue
3
Pages
244-252
ISSN
1528-9117
DOI
10.1097/ppo.0b013e318258b78f
PMC
PMC3397427
Cited by
252
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review